Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma - Concepedia

Concepedia

Publication | Closed Access

Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma

35

Citations

39

References

2001

Year

Andrea Ardizzoni, Mara A. Cafferata, M. Paganuzzi, Rosangela Filiberti, Paola Marroni, Monica Neri, Vincenzo Fontana, G. D. Nicol, Luisa Perdelli, Corrado Gallo Stampino,

Abstract

High pretreatment levels of HER-2/neu oncoprotein are associated with an adverse prognostic impact on survival in patients with locally advanced or metastatic nonsmall cell lung carcinoma.

References

	Year	Citations

Page 1